Prescription charges would boost research
WE have all read about the problems within A&Es, the mixed news on canceri mortality rates, and the gross inefficiency and wastage within the prescriptions process.
Cancer mortality rates generally have reduced by 25% over the last 25 years. But, within those statistics hide some horrific facts regarding pancreas and lung cancer. Overall survival rates are scandalously below those in France or Spain.
I firmly believe the majority of us would return to paying for our prescriptions if the £400m annual saving was redirected to our A&E service and cancer research.
Enniskillen, Co Fermanagh